Abstract:Background Epigenetic alternation is a common contributing factor to neoplastic transformation. Although previous studies have reported a cluster of aberrant promoter methylation changes associated with silencing of tumor suppressor genes, little is known concerning their sequential DNA methylation changes during the carcinogenetic process. The aim of the present study was to address a genome-wide search for identifying potentially important methylated changes and investigate the onset and pattern of methylation changes during the progression of colorectal neoplasia. Methods A three-phase design was employed in this study. In the screening phase, DNA methylation profile of 12 pairs of colorectal cancer (CRC) and adjacent normal tissues was analyzed by using the Illumina MethylationEPIC BeadChip. Significant CpG sites were selected based on a cross-validation analysis from The Cancer Genome Atlas (TCGA) database. Methylation levels of candidate CpGs were assessed using pyrosequencing in the training dataset (tumor lesions and adjacent normal tissues from 46 CRCs) and the validation dataset (tumor lesions and paired normal tissues from 13 hyperplastic polyps, 129 adenomas, and 256 CRCs). A linear mixed-effects model was used to examine the incremental changes of DNA methylation during the progression of colorectal neoplasia. Results The comparisons between normal and tumor samples in the screening phase revealed an extensive CRC-specific methylomic pattern with 174,006 (21%) methylated CpG sites, of which 22,232 (13%) were hyermethylated and 151,774 (87%) were hypomethylated. Hypermethylation mostly occurred in CpG islands with an overlap of gene promoters, while hypomethylation tended to be mapped far away from functional regions. Further cross validation analysis from TCGA dataset confirmed 265 hypermethylated promoters coupling with downregulated gene expression. Among which, hypermethylated changes in MEEPD2 promoter was successfully replicated in both training and validation phase. Significant hypermethylation appeared since precursor lesions with an extensive modification in CRCs. The linear mixed-effects modeling analysis found that a cumulative pattern of MPPED2 methylation changes from normal mucosa to hyperplastic polyp to adenoma, and to carcinoma ( P < 0.001). Conclusions Our findings indicate that epigenetic alterations of MPPED2 promoter region appear sequentially during the colorectal neoplastic progression. It might be able to serve as a promising biomarker for early diagnosis and stage surveillance of colorectal tumorigenesis.

Foreground of DNA Methylation in Diagnosis and Therapy of Colorectal Cancer

Noninvasive DNA Methylation Biomarkers in Colorectal Cancer: A Systematic Review.

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

Epigenetics and colorectal cancer

Research progress of DNA methylation in colorectal cancer (Review)

Epigenetic Changes in Colorectal Cancer

Epigenetic changes in colorectal cancer.

DNA methylation biomarkers for early detection of gastric and colorectal cancers

Epigenetic Silencing of Protocadherin 10 in Colorectal Cancer.

Genome-wide Analysis of Aberrant DNA Methylation for Identification of Potential Biomarkers in Colorectal Cancer Patients.

DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer

Value of Ctdna Methylation Biomarkers in Diagnosis of Colorectal Tumors

Field Cancerization in the Colon: a Role for Aberrant DNA Methylation?

Identification of Regulatory Role of DNA Methylation in Colon Cancer Gene Expression Via Systematic Bioinformatics Analysis

Clinical Application of Marker Based on DNA Methylation in Gastrointestinal Tumor

Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications

DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer

Translational Application of DNA Methylation Biomarkers in Malignant Tumors

Advances on DNA Methylation for Noninvasive Tumor Molecular Diagnosis